美国儿科心脏病学市场规模和预测（2021 - 2031 年）、国家份额、趋势和增长机会分析报告范围：按产品类型（经导管心脏瓣膜、封堵装置、动脉粥样硬化切除装置、导管、支架、导管鞘等）、外科手术（介入手术、心律管理手术等）、最终用户（医院、专科诊所等）、疾病适应症 [患者卵圆孔 (PFO)、先天性心脏病、后天性心脏病、心律失常、心肌病等] 和国家
儿科心脏病学是医学的一个专业分支，专注于诊断、治疗和管理婴儿、儿童和青少年的心脏病。该领域涉及一系列先天性（出生时存在）和后天性心脏缺陷，包括室间隔缺损、房间隔缺损等疾病以及需要手术干预的更复杂问题。
公司的战略举措
在美国儿科心脏病学市场运营的公司不断专注于战略发展，例如产品审批、合作、资金、协议和新产品发布，这有助于他们提高销售额、扩大地理覆盖范围和满足广泛客户群的能力。以下是美国儿科心脏病学市场主要参与者采取的一些战略举措：
• 2024 年 1 月，Occlutech 获得美国食品药品监督管理局 (FDA) 的 Occlutech Pistol Pusher 和 Occlutech ASD 封堵器，用于治疗房间隔缺损 (ASD)。获得此项批准后，Occlutech 将立即与分销商 B. Braun Interventional Systems Inc. 建立独家合作伙伴关系，开始商业化。Occlutech ASD 封堵器是一种镍钛合金自膨胀双盘封堵装置，由两个伞状柔性盘组成，中间有一个腰部连接两个盘。
• 2023 年 2 月，美敦力重新推出了其 Harmony 经导管肺动脉瓣 (TPV) 系统，这是一种微创的开胸手术替代方案，适用于具有原生或手术修复的右心室流出道 (RVOT) 的先天性心脏病患者。该系统专为患有 RVOT 异常且患有严重肺动脉瓣反流的患者设计，肺动脉瓣反流是指血液被泵入肺部后漏入心脏右下腔的疾病。
• 2022 年 5 月，Occlutech 与 B. Braun Interventional Systems Inc (BIS) 签署了独家分销协议。BIS 将在全球 Occlutech 团队的支持下启动 Occlutech Flex II ASD Occluder 的美国商业化活动。通过此次合作，Occlutech 在具有重要战略意义的美国市场取得了成功，该市场被描述为首屈一指且具有商业吸引力的医疗保健系统。此外，BIS 通过对先天性和结构性心脏的强烈关注，提高了其产品组合的相关性。
因此，各公司专注于儿科心脏病学设备开发的战略举措可能会在未来几年为美国儿科心脏病学市场提供增长机会。
然而，缺乏熟练的儿科心脏病专家正在影响患有心血管疾病的儿童的护理的可用性和质量。随着先天性心脏缺陷和其他心脏疾病的发病率不断上升，对专业心脏病服务的需求超过了训练有素的专业人员的供应。此外，人们越来越意识到预防性心脏病护理可以解决出生后长期的儿科心脏病问题。根据美国儿科学会的数据，儿科心脏病专家明显短缺，特别是在美国农村和服务不足的地区，这些地区获得专业护理的机会往往有限。根据美国儿科学会 (ABP) 截至 2023 年 6 月的数据，共有 4,117 名儿科心脏病专家获得过委员会认证，其中 3,096 名 (75%) 积极参加维护认证 (MOC)。如果将劳动力限制在美国，2023 年每个州平均有 57.3 名获得委员会认证的儿科心脏病专家（范围为 0-329），这意味着全美每 100,000 名 17 岁以下儿童就有 4 名心脏病专家（范围为 0.0-25.4）。各州内儿科心脏病专家的分布差异很大，大多数集中在城市地区，农村地区则很少。儿科心脏病专家的短缺也增加了现有从业人员的压力，导致职业倦怠和工作不满。这种情况最终会影响患者的治疗结果，因为工作过度的专家可能无法为复杂病例提供所需的全面护理。因此，熟练的儿科心脏病专家的缺乏阻碍了市场的增长。
基于最终用户的见解
根据最终用户，儿科心脏病学市场分为医院、专科诊所和其他。医院部门在 2023 年占据了市场主导地位。在美国儿科心脏病学市场中，医院部门在为患有心血管疾病的儿童提供专业护理方面具有重要意义。先天性心脏缺陷和其他心脏病病例的增加，使儿科心脏中心拥有现代技术和多学科团队进行全面治疗。波士顿儿童医院、德克萨斯儿童医院、西雅图儿童医院和费城儿童医院是公认的领导者，拥有最先进的设施和创新的儿科心脏病学方法——包括微创手术技术和介入程序。这些医院强调协作护理，心脏病专家与其他外科医生、麻醉师和护理人员合作，以确保优化治疗效果。西雅图儿童医院在 2023 年进行了约 570 例儿科心脏手术。最近对远程医疗和远程监控技术的投资进一步加强了患者管理，持续的护理和随访对于农村地区的患者来说非常必要。获得卫生系统中增强的专门护理和治疗方案可确保医院部门的增长和儿科心脏病学的进步，这将改善患有心血管疾病的年轻患者的生活质量。
美国心脏病学会、儿童心脏基金会、疾病控制和预防中心、美国食品药品监督管理局和美国儿科学会是编写美国儿科心脏病学市场报告时参考的主要和次要来源。
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. US Pediatric Cardiology Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 US Sternotomy Procedure Analysis
5. US Pediatric Cardiology Market – Key Market Dynamics
5.1 US Pediatric Cardiology Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Increasing Incidence of Congenital Heart Disease in Pediatrics
5.2.2 Growing Shift Toward Minimally Invasive Procedures
5.3 Market Restraints
5.3.1 Dearth of Skilled Pediatric Cardiologists
5.4 Market Opportunities
5.4.1 Strategic Initiatives by Companies
5.5 Future Trends
5.5.1 Integration of AI and Machine Learning with Pediatric Cardiology
5.6 Impact of Drivers and Restraints:
6. US Pediatric Cardiology Market Analysis
6.1 US Pediatric Cardiology Market Revenue (US$ Million), 2021–2031
7. US Pediatric Cardiology Market Analysis – by Product Type
7.1 Transcatheter Heart Valves
7.1.1 Overview
7.1.2 Transcatheter Heart Valves: US Pediatric Cardiology Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Occlusion Devices
7.2.1 Overview
7.2.2 Occlusion Devices: US Pediatric Cardiology Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Atherectomy Devices
7.3.1 Overview
7.3.2 Atherectomy Devices: US Pediatric Cardiology Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Catheters
7.4.1 Overview
7.4.2 Catheters: US Pediatric Cardiology Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Stents
7.5.1 Overview
7.5.2 Stents: US Pediatric Cardiology Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Introducer Sheaths
7.6.1 Overview
7.6.2 Introducer Sheaths: US Pediatric Cardiology Market – Revenue and Forecast to 2031 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: US Pediatric Cardiology Market – Revenue and Forecast to 2031 (US$ Million)
8. US Pediatric Cardiology Market Analysis – by Surgical Procedures
8.1 Interventional Procedures
8.1.1 Overview
8.1.2 Interventional Procedures: US Pediatric Cardiology Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Heart Rhythm Management Procedures
8.2.1 Overview
8.2.2 Heart Rhythm Management Procedures: US Pediatric Cardiology Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Others
8.3.1 Overview
8.3.2 Others: US Pediatric Cardiology Market – Revenue and Forecast to 2031 (US$ Million)
9. US Pediatric Cardiology Market Analysis – by End User
9.1 Hospitals
9.1.1 Overview
9.1.2 Hospitals: US Pediatric Cardiology Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Specialty Clinics
9.2.1 Overview
9.2.2 Specialty Clinics: US Pediatric Cardiology Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Others
9.3.1 Overview
9.3.2 Others: US Pediatric Cardiology Market – Revenue and Forecast to 2031 (US$ Million)
10. US Pediatric Cardiology Market Analysis – by Disease Indication
10.1 Patient Foramen Ovale (PFO)
10.1.1 Overview
10.1.2 Patient Foramen Ovale (PFO): US Pediatric Cardiology Market – Revenue and Forecast to 2031 (US$ Million)
10.2 Congenital Heart Disease
10.2.1 Overview
10.2.2 Congenital Heart Disease: US Pediatric Cardiology Market – Revenue and Forecast to 2031 (US$ Million)
10.3 Acquired Heart Disease
10.3.1 Overview
10.3.2 Acquired Heart Disease: US Pediatric Cardiology Market – Revenue and Forecast to 2031 (US$ Million)
10.4 Arrhythmias
10.4.1 Overview
10.4.2 Arrhythmias: US Pediatric Cardiology Market – Revenue and Forecast to 2031 (US$ Million)
10.5 Cardiomyopathies
10.5.1 Overview
10.5.2 Cardiomyopathies: US Pediatric Cardiology Market – Revenue and Forecast to 2031 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: US Pediatric Cardiology Market – Revenue and Forecast to 2031 (US$ Million)
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in US Pediatric Cardiology Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Abbott Laboratories
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Medtronic Plc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Edwards Lifesciences Corp
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Terumo Corp
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 W L Gore and Associates Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 NuMED
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Cordis Corp
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Occlutech US LLC
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Biotronik SE & Co KG
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 RENATA MEDICAL
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
List of Tables
Table 1. US Pediatric Cardiology Market Segmentation
Table 2. US Pediatric Cardiology Market – Volume and Forecast to 2031 (Units) – by Product Type
Table 3. US Pediatric Cardiology Market – Volume and Forecast to 2031 (Units) – by Surgical Procedures
Table 4. US Pediatric Cardiology Market – Volume and Forecast to 2031 (Units) – by Disease Indication
Table 5. Recent Organic Growth Strategies in US Pediatric Cardiology Market
Table 6. Recent Inorganic Growth Strategies in the US Pediatric Cardiology Market
Table 7. Glossary of Terms, US Pediatric Cardiology Market
List of Figures
Figure 1. US Pediatric Cardiology Market Segmentation, by Country
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. US Pediatric Cardiology Market Revenue (US$ Million), 2021–2031
Figure 5. US Pediatric Cardiology Market Share (%) – by Product Type, 2023 and 2031
Figure 6. Transcatheter Heart Valves: US Pediatric Cardiology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. Occlusion Devices: US Pediatric Cardiology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Atherectomy Devices: US Pediatric Cardiology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 9. Catheters: US Pediatric Cardiology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. Stents: US Pediatric Cardiology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Introducer Sheaths: US Pediatric Cardiology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 12. Others: US Pediatric Cardiology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. US Pediatric Cardiology Market Share (%) – by Surgical Procedures, 2023 and 2031
Figure 14. Interventional Procedures: US Pediatric Cardiology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 15. Heart Rhythm Management Procedures: US Pediatric Cardiology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. Others: US Pediatric Cardiology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 17. US Pediatric Cardiology Market Share (%) – by End User, 2023 and 2031
Figure 18. Hospitals: US Pediatric Cardiology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 19. Specialty Clinics: US Pediatric Cardiology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 20. Others: US Pediatric Cardiology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 21. US Pediatric Cardiology Market Share (%) – by Disease Indication, 2023 and 2031
Figure 22. Patient Foramen Ovale (PFO): US Pediatric Cardiology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 23. Congenital Heart Disease: US Pediatric Cardiology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 24. Acquired Heart Disease: US Pediatric Cardiology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 25. Arrhythmias: US Pediatric Cardiology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 26. Cardiomyopathies: US Pediatric Cardiology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 27. Others: US Pediatric Cardiology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 28. Growth Strategies in US Pediatric Cardiology Market
- Abbott Laboratories
- Medtronic Plc
- Edwards Lifesciences Corp
- Terumo Corp
- W L Gore & Associates Inc
- NuMED
- Cordis Corp
- Occlutech US LLC
- Biotronik SE & Co KG
- RENATA MEDICAL
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the US pediatric cardiology market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the US pediatric cardiology market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.